The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: an open-label study von Becker, M O, Brückner, C, Scherer, H U, Wassermann, N, Humrich, J Y, Hanitsch, L G, Schneider, U, Kawald, A, Hanke, K, Burmester, G R, Riemekasten, G

Volltext

The unusual mimicker of a polymyositis von Jendrek, S T, Glatzel, M, Pauli, D, Schinke, S, Humrich, J Y, Lamprecht, P, Riemekasten, G

Volltext

The highly attenuated vaccinia virus strain modified virus Ankara induces apoptosis in melanoma cells and allows bystander dendritic cells to generate a potent anti‐tumoral immunit... von Greiner, S., Humrich, J. Y., Thuman, P., Sauter, B., Schuler, G., Jenne, L.

Volltext

S11.3 Low-dose interleukin-2 therapy in active systemic lupus erythematosus (lupil-2): a multi-center, double-blind, randomized and placebo-controlled phase 2 trial von Humrich, J, Cacoub, P, Rosenzwajg, M, Pitoiset, F, Pham, H, Guidoux, J, Leroux, D, Vazquez, T, Riemekasten, G, Smolen, J, Tsokos, G, Klatzmann, D

Volltext

AB0120 Il-2 therapy results in intrarenal foxp3+ regulatory t cells expansion and decreased number of infiltrating cd4+ t cells in nzb/w mice von Rose, A., von Spee-Mayer, C., Humrich, J., Riemekasten, G.

Volltext

AB0169 IL-2 Therapy Decreases Total Number of Kidney Infiltrating CD4+ T Cells and Reduces the Cellular Activity of CD4+ Effector T Cells in NZB/W Mice von Rose, A., von Spee-Mayer, C., Kloke, L., Humrich, J., Riemekasten, G.

Volltext

OP0104 Low-Dose Interleukin-2 Therapy Caused Selective Expansion of Regulatory T Cells Together with RAPID Reduction of Disease Activity in A Patient with Severe Refractory Sle von Von Spee-Mayer, C., Siegert, E., Rose, A., Humrich, J., Riemekasten, G.

Volltext

Regulatory T cells and rheumatic diseases von Humrich, J Y, Kamradt, T, Riemekasten, G

Volltext

Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease von FRÖLICH, L, BLUM-DEGEN, D, ZÖCHLING, R, BOISSL, K. W, JELLINGER, K, RIEDERER, P, BERNSTEIN, H.-G, ENGELSBERGER, S, HUMRICH, J, LAUFER, S, MUSCHNER, D, THALHEIMER, A, TÜRK, A, HOYER, S

Volltext

SAT0182 Urinary T cells identify SLE patients with proliferative lupus nephritis and may be used to monitor treatment response von Enghard, P., Rieder, C., Kopetschke, K., Klocke, J., Humrich, J., Undeutsch, R., Biesen, R., Burmester, G.-R., Riemekasten, G.

Volltext

AB0122 Regulatory t cell abnormalities and il-2 deficiency in patients with systemic lupus erythematosus von von Spee-Mayer, C., Wassermann, N., Rose, A., Alexander, T., Klocke, J., Humrich, J. Y., Riemekasten, G.

Volltext

CD4 T cells producing IL-10 have a beneficial effect in murine lupus von Undeutsch, R, Humrich, J Y, Papendieck, A, Riemekasten, G

Volltext

IL-2-Therapy in SLE- Selective reconstitution of immunological tolerance von Humrich, J Y, Riemekasten, G

Volltext

Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus von Humrich, J, Undeutsch, R, Kloke, L, Burmester, G-R, Riemekasten, G

Volltext

Diagnosis of deficiency of adenosine deaminase 2 with early onset polyarteritis nodosa in an adult patient with a novel compound heterozygous CECR1 mutation von Lamprecht, Peter, Humrich, Jens Y, Diebold, Isabel, Riemekasten, Gabriela

Volltext

Der außergewöhnliche Nachahmer einer Polymyositis von Jendrek, S. T., Glatzel, M., Pauli, D., Schinke, S., Humrich, J. Y., Lamprecht, P., Riemekasten, G.

Volltext

A3.12Intrarenal Foxp3+ Regulatory T Cells Expansion and Decreased Number of Infiltrating CD4+ T Cells in Murine Lupus by IL-2 Therapy von Rose, A, Humrich, J Y, Riemekasten, G

Volltext

Effects of two Gβγ-binding proteins - N-terminally truncated phosducin and β-adrenergic receptor kinase C terminus (βARKct) - in heart failure von Li, Z, Laugwitz, K-L, Pinkernell, K, Pragst, I, Baumgartner, C, Hoffmann, E, Rosport, K, Münch, G, Moretti, A, Humrich, J, Lohse, M J, Ungerer, M

Volltext

Mature monocyte‐derived dendritic cells respond more strongly to CCL19 than to CXCL12: consequences for directional migration von Humrich, Jens Y., Humrich, Jan H., Averbeck, Marco, Thumann, Peter, Termeer, Christian, Kämpgen, Eckhart, Schuler, Gerold, Jenne, Lars

Volltext

SP0137 Low-Dose IL-2 Therapy in Refractory SLE: Early Insights from a Phase I/IIA Clinical Trial von Humrich, J.Y.

Volltext